Linked Data API

Show Search Form

Search Results

1225148
registered interest false more like this
date less than 2020-07-15more like thismore than 2020-07-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Multiple Sclerosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people affected by secondary progressive multiple sclerosis. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper more like this
uin 74470 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-07-23more like thismore than 2020-07-23
answer text <p>The National Institute for Health and Care Excellence estimates that secondary progressive multiple sclerosis (MS) affects around 9,000 people in England. Secondary progressive MS is a stage which comes after relapsing remitting MS for many people with the condition. After a diagnosis of relapsing remitting MS has been established, clinicians will observe the patient's symptoms over a period of time, in order to determine if they are associated with secondary progressive MS. With this type of MS, a person’s disability gets steadily worse and they are less likely to have relapses (when symptoms get worse but then get better).</p> more like this
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
grouped question UIN 74471 more like this
question first answered
less than 2020-07-23T11:36:53.24Zmore like thismore than 2020-07-23T11:36:53.24Z
answering member
4527
label Biography information for Helen Whately more like this
previous answer version
38832
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
answering member
4527
label Biography information for Helen Whately more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
1225150
registered interest false more like this
date less than 2020-07-15more like thismore than 2020-07-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Multiple Sclerosis: Diagnosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the diagnosis of secondary progressive multiple sclerosis. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper more like this
uin 74471 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-07-23more like thismore than 2020-07-23
answer text <p>The National Institute for Health and Care Excellence estimates that secondary progressive multiple sclerosis (MS) affects around 9,000 people in England. Secondary progressive MS is a stage which comes after relapsing remitting MS for many people with the condition. After a diagnosis of relapsing remitting MS has been established, clinicians will observe the patient's symptoms over a period of time, in order to determine if they are associated with secondary progressive MS. With this type of MS, a person’s disability gets steadily worse and they are less likely to have relapses (when symptoms get worse but then get better).</p> more like this
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
grouped question UIN 74470 more like this
question first answered
less than 2020-07-23T11:36:53.303Zmore like thismore than 2020-07-23T11:36:53.303Z
answering member
4527
label Biography information for Helen Whately more like this
previous answer version
38833
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
answering member
4527
label Biography information for Helen Whately more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
1225152
registered interest false more like this
date less than 2020-07-15more like thismore than 2020-07-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Multiple Sclerosis: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what support his Department is providing to local NHS services to improve the care of people with secondary progressive multiple sclerosis. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper more like this
uin 74472 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-07-23more like thismore than 2020-07-23
answer text <p>In order to improve the care and outcomes for people with progressive neurological conditions, such as secondary progressive multiple sclerosis (MS), NHS England and NHS Improvement produced a progressive neurological conditions RightCare toolkit, in collaboration with key stakeholders such as the MS Trust and the MS Society. This toolkit supports systems to understand the priorities in care for people living with various progressive neurological conditions, in line with best practice guidelines.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Multiple sclerosis in adults: management’, updated in 2019 sets out best practice on the diagnosis, treatment, care and support of people MS. On secondary progressive MS, the guidance sets out that “While a variety of symptomatic treatments is available, progression in secondary progressive MS is currently intractable, and immunomodulatory strategies used for relapse remitting MS have not proven effective when extended into secondary progressive MS.”</p><p> </p><p> </p>
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
grouped question UIN 74473 more like this
question first answered
less than 2020-07-23T11:44:05.84Zmore like thismore than 2020-07-23T11:44:05.84Z
answering member
4527
label Biography information for Helen Whately more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
1225153
registered interest false more like this
date less than 2020-07-15more like thismore than 2020-07-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Multiple Sclerosis: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve outcomes for people living with secondary progressive multiple sclerosis. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper more like this
uin 74473 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-07-23more like thismore than 2020-07-23
answer text <p>In order to improve the care and outcomes for people with progressive neurological conditions, such as secondary progressive multiple sclerosis (MS), NHS England and NHS Improvement produced a progressive neurological conditions RightCare toolkit, in collaboration with key stakeholders such as the MS Trust and the MS Society. This toolkit supports systems to understand the priorities in care for people living with various progressive neurological conditions, in line with best practice guidelines.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Multiple sclerosis in adults: management’, updated in 2019 sets out best practice on the diagnosis, treatment, care and support of people MS. On secondary progressive MS, the guidance sets out that “While a variety of symptomatic treatments is available, progression in secondary progressive MS is currently intractable, and immunomodulatory strategies used for relapse remitting MS have not proven effective when extended into secondary progressive MS.”</p><p> </p><p> </p>
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
grouped question UIN 74472 more like this
question first answered
less than 2020-07-23T11:44:05.88Zmore like thismore than 2020-07-23T11:44:05.88Z
answering member
4527
label Biography information for Helen Whately more like this
tabling member
1538
label Biography information for Rosie Cooper more like this
1225154
registered interest false more like this
date less than 2020-07-15more like thismore than 2020-07-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Multiple Sclerosis: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he plans to take to implement the recommendations of the report, The Forgotten Many: A 2020 Vision for Secondary Progressive Multiple Sclerosis, published in June 2020. more like this
tabling member constituency West Lancashire more like this
tabling member printed
Rosie Cooper more like this
uin 74474 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-08-04more like thismore than 2020-08-04
answer text <p>‘The Forgotten Many: A 2020 Vision for Secondary Progressive Multiple Sclerosis’, was published in June 2020 and was funded by Novartis.</p><p>The report sets out a wide range of recommendations for NHS England and NHS Improvement and local commissioners around awareness, treatment pathways and support. NHS England and NHS Improvement are aware of the report, and a range of activity is underway to improve awareness, treatment, care and support for people neurological conditions, including secondary progressive multiple sclerosis (SPMS), which are relevant to the recommendations.</p> more like this
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
question first answered
less than 2020-08-04T13:59:50Zmore like thismore than 2020-08-04T13:59:50Z
answering member
4527
label Biography information for Helen Whately more like this
previous answer version
38834
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
answering member
4527
label Biography information for Helen Whately more like this
tabling member
1538
label Biography information for Rosie Cooper more like this